Vireo Growth (FRA:K95) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


FRA:K95 Vireo Growth Inc FRA:K95
44 GF Score
Price €8.42
GF Value €7.54
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vireo Growth's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:K95 vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vireo Growth Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Margin of Safety % (DCF FCF Based) falls into.


FRA:K95
44GF Score
Vireo Growth Inc FRA:K95
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vireo Growth (FRA:K95) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of €8.42 is trading 11.7% above its estimated GF Value™ of €7.54. GuruFocus considers Vireo Growth to be Modestly Overvalued.

Key valuation signals for FRA:K95:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €7.54 vs. price of €8.42 (11.7% above fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the FRA:K95 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vireo Growth Business Description

Other Exchanges VREOD:USAVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
44GF Score

Get the complete analysis for FRA:K95

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.42
Price
€7.54
GF Value